Patent details

EP3130583 Title: KYNURENINE-3-MONOOXYGENASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Unitary Effect

Unitary Effect Requested:
Yes
Unitary Effect Request Filing Date:
02/02/2024
Unitary Effect Status:
Unitary Effect Registered
Request Unitary Effect Accepted:
12/02/2024
Unitary Effect Date:
03/01/2024
Unitary Effect Registration Date:
12/02/2024
Request Unitary Effect Rejected:
Unitary Effect Re-establishment of rights Filing Date:
Unitary Effect Re-establishment of rights EPO Decision :
Unitary Effect Re-establishment of rights EPO Decision Date:
Unitary Effect Request Withdrawal Date:
Unitary Effect request has been accepted, please see the UPP register at the EPO for up-to-date information
UPP register:
EP3130583
SPC Number:
Creation Date:

Basic Information

Publication number:
EP3130583
WO Application Number:
Type:
European Patent Granted for NL
Status:
Unitary Effect Registered
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP16186005.1
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
13/03/2013
Grant date:
03/01/2024
EP Publication Date:
15/02/2017
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
03/01/2024
EP B1 Publication Date:
03/01/2024
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
12/03/2033
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
03/01/2024
 
 

 

Name:
CHDI Foundation, Inc.
Address:
350 Seventh Ave Suite 200, New York, NY 10001, United States of America (US)

Inventor

1

Name:
TOLEDO-SHERMAN,, Leticia, M
Address:
Santa Monica,, CA California 90405, United States of America (US)

2

Name:
DOMINGUEZ,, Celia
Address:
Los Angeles,, CA California 90046, United States of America (US)

3

Name:
PRIME,, Michael
Address:
Abingdon, Oxfordshire OX14 5NB, United Kingdom (GB)

4

Name:
MITCHELL,, William, Leonard
Address:
Market Rasen, Lincolnshire LN7 6DE, United Kingdom (GB)

5

Name:
JOHNSON,, Peter
Address:
Abingdon, Oxfordshire OX14 5ND, United Kingdom (GB)

6

Name:
WENT,, Naomi
Address:
Didcot, Oxfordshire OX11 7RR, United Kingdom (GB)

Priority

Priority Patent Number:
201261620953 P
Priority Date:
05/04/2012
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
C07D 203/08; C07D 305/06; C07D 305/08; C07C 62/38; A61P 25/00; A61P 25/16; A61P 25/28;

Publication

Bulletin

1

Bulletin Heading:
UP1
Journal edition number:
11/24
Publication date:
13/03/2024
Description:
European patents with registered Unitary Effect

2

Bulletin Heading:
EP2
Journal edition number:
01/24
Publication date:
03/01/2024
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
202411
Publication date:
13/03/2024
Description:
Unitary Effect Request Receipt

2

Issue number:
202411
Publication date:
13/03/2024
Description:
Unitary Effect Request Acceptance

3

Issue number:
202401
Publication date:
03/01/2024
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type